SCHEMBL31201686

SCHEMBL31201686

Fc1ccc(Cn2cnc(Cl)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 6/20 0.49
HDAC6 Q9UBN7 6/20 0.49
MAPT P10636 3/20 0.44
LMNA P02545 2/20 0.44
CYP11B1 P15538 2/20 0.43
CYP11B2 P19099 2/20 0.43
CYP19A1 P11511 1/20 0.43
KMT2A Q03164 2/20 0.41
SLC2A1 P11166 1/20 0.39
RAB9A P51151 3/20 0.39
KDM4E B2RXH2 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
NPC1 O15118 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
THRB P10828 1/20 0.39
MITF O75030 1/20 0.38
PKM P14618 1/20 0.38
HTT P42858 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31201590 0.81 SMN1; SMN2 (0.45) HDAC1HDAC6MAPTLMNACYP11B1
SCHEMBL25416318 0.81 CYP19A1 (0.48) HDAC1HDAC6MAPTLMNACYP11B1
SCHEMBL28857469 0.80 HDAC1 (0.48) HDAC1HDAC6MAPTLMNACYP11B1
SCHEMBL2276464 0.80 LMNA (0.50) HDAC1HDAC6MAPTLMNACYP11B1
SCHEMBL31201753 0.79 CYP11B1 (0.44) HDAC1HDAC6MAPTCYP11B1CYP11B2
SCHEMBL30992851 0.77 ALDH1A1 (0.46) HDAC1HDAC6MAPTLMNACYP11B1
SCHEMBL31272149 0.77 POLB (0.40) HDAC1HDAC6MAPTLMNAKMT2A
SCHEMBL31201452 0.76 LMNA (0.43) HDAC1HDAC6MAPTLMNAKMT2A
SCHEMBL2578582 0.75 HDAC1 (0.64) HDAC1HDAC6MAPTLMNACYP11B1
SCHEMBL18366892 0.75 HDAC1 (0.53) HDAC1HDAC6LMNARAB9ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709725-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF Progentos Therapeutics, Inc. (US) 2026-03-18 EP disclosed
WO-2024233642-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF PROGENTOS THERAPEUTICS, INC. (US) 2024-11-14 WO disclosed